Research Funding

Ongoing 

  • 2023-2026 Grant Agency of Charles University: Bioanalytical study on the potential of VAMS coupled with miniaturized sample preparation for the analysis of selected drugs in preclinical research. (GAUK No. 232223)
  • 2021-2024  Grant Agency of Charles University: Complex approach to the development of a separation method for the research of catecholamines in a placenta (GAUK No. 349521)
  • 2020-2024 AZV - Placental tryptophan metabolism linking maternal inflammation and foetal neurodevelopmental disorders.

Past

  • 2017-2019 Czech Science Foundation: Azaphthalocyanines – dark quenchers in DNA hybridization probes. (GAČR: 17-19094S)
  • 2017-2019 : Grant Agency of Charles University: Utilization of UHPLC-MS/MS for study of the fate of new cardioprotective drugs in cardiac cells and in an organism.  (GAUK No. 1550217)
  • 2012-2017 Charles University: UNCE project “Centre for investigation of toxic and protective effects of drugs on cardiovascular system” (UNCE 33/2012).
  • 2015-2017 Grant Agency of Charles University: "Comprehensive analytical and bioanalytical study of sobuzoxane – a new anti-cancer drug" (GAUK No. 344615).
  • 2014-2016 Grant Agency of Charles University: "Bioanalytical study on metabolism and bioactivation of novel cardioprotective drugs" (GAUK No. 1324214).
  • 2013-2015 Grant Agency of Charles University: "Novel anti-tumor agents derived from thiosemicarbazone – LC/MS study of metabolism and pharmacokinetics" (GAUK No. 903113)
  • 2012-2014 Grant Agency of Charles University: “Possibilities of metal oxide-based materials in sample preparation and separation of complex analytes” (631612/2011/B-CH/FaF)
  • 2013 FRVŠ: "Innovation and development of laboratory for practical training in pharmaceutical analysis and bioanalysis" (577/2013)
  • 2012 FRVŠ: “Innovation and development of instrumental laboratories for drug analysis” (366/2012)
  • 2010-2013 Internal Grant Agency of Ministry of Health: “Pharmaceutical analysis, pharmacokinetic and biotransformation study of novel thiosemicarbazone anticancer drugs.“ (NT12403-3/2011)
  • 2010-2012 Czech Science Foundation: “Modern bioanalytical contribution to the interdisciplinary investigation of bisdioxopiperazine cardioprotective agents”   (GAČR: P206/10P439).
  • 2010-2012 - Grant Agency of Charles University: “Bioanalytical study of the fate of novel thiosemicarbazone antineoplastics in organism“ (85510/2010/B-CH/FaF)
  • 2009-2010 Grant Agency of Charles University: „Analytical study of the role of hydrazones‘ metabolites in isoniazid intoxication”(4212/2009/B-CH/FaF)
  • 2009 FRVŠ: “The employment of zirconia-based stationary phases in drug analysis” (1081/2009)
  • 2006-2007 Grant Agency of Charles University: “Pharmacutical-analytical approach to the investigation of novel drug candidates from the group of iron chelators“ (284/2006/B-CH/FaF)
  • 2006-2007 Grant Agency of Charles University: “The possibilities of employment of modern HPLC stationary phases in the pharmaceutical analysis”
  • 2006 FRVŠ: “Innovation of the subjects Drug Analysis and Therapeutic Drug Monitoring“ (1319/2006)
  • 2006 FRVŠ: “Analysis of Drugs in Biological Material – Multimedial Material for Education” (760/2006)
  • 2006 FRVŠ: “The use of head-space gas chromatogramy in the drug control” (388/2006)
  • 2005-2011 Ministry of Education, Youth and Sports: Institutional research plan “Research of novel drug structures” (MSM0021620822).
  • 2005-2007 Ministry of Industry and Trade: programme TANDEM, FT-TA2/012 “Modulators of skin barrier function and their use in the drug development”
  • 2005 Ministry of Education, Youth and Sports: “Support of entry of graduate bachelor study program „ Zdravotnická bioanalytika“ on labour market”
  • 2004 Grant Agency of Charles University: “Development of HPLC evaluation of novel drug candidates from the group of pyridoxal isonicotinoyl hydrazone analogues and the application to the analysis of biological materials” (395/2004/B-CH/FaF)
  • 2004 FRVŠ: “The chiral separation in drug analysis using electromigration methods“ (938/2004)
  • 2004 FRVŠ: “Stability study of pyridoxal isonicotinoyl hydrazone“ (952/2004)
  • 2004 FRVŠ: “The innovation of the subject Drug control of the study programme Pharmacy” (940/2004)
  • 2004 FRVŠ: “The innovation of practical training of the subject pharmaceutical analysis“ (937/2004)
  • 2002 FRVŠ: “Practical Education of Drug Analysis of Study Programme Medical Bioanalytics“ (2230/2002)
  • 2002 FRVŠ: “The monitoring of nimesulide, diclofenac and their main metabolites” (2241/2002)
  • 2000-2007 Ministry of Education, Youth and Sports: Development Project 6c,“Transformation, development, evaluation of quality and success of the doctoral study programme in the field of Drug Control and Pharmaceutical Analysis”
  • 2006: Investment grant project FRVŠ: “Innovation of the laboratory for practical training in pharmaceutical-analytical instrumental methods” (668/2006)
  • 2000 – 2002 Grant Agency of Charles University: “Determination of Lipophilicity of Potential Antituberculous Drugs by Reversed-Phase High Performance Liquid Chromatography“(237/2000/B-CH/FaF)
  • 1999-2004 Ministry of Education, Youth and Sports: Institutional research plan “Development, preparation and technology of pharmaceuticals” (MSM 111600001)
  • 1998-2000 Grant Agency of Charles University: “Study of adjustment of biological samples before HPLC analysis“  
  • 1986-1990: Project of the State Plan of Technical Development  “Evaluation and standardization of medicinal drugs” (P12/335/822/01)
  • 1996-1998: Grant Agency of Charles University: “Pharmaceutical analytical studies of pharmaceuticals using liquid chromatography” (131/1996/C/FaF)
  • 1995: grant project FRVŠ:  “Therapeutical Drug Monitoring” (0607/07/95)

© Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic
Website information | Powered by Kentico